Skip to content
Clinical Trials – home

Etrasimod: A Promising New Treatment for Autoimmune Conditions

1 / 1
trials open to patients / all trials
1+
Countries

In short

Etrasimod is an investigational drug currently being studied in clinical trials for several autoimmune conditions, including ulcerative colitis, Crohn's disease, eosinophilic esophagitis, and alopecia areata. This article summarizes key findings from recent clinical trials evaluating the safety and effectiveness of etrasimod in treating these conditions.

What is etrasimod?

Etrasimod is an investigational medication being studied for the treatment of various autoimmune conditions. It is also known by the names APD334 and PF-07915503. Etrasimod is taken orally as a tablet and is currently undergoing clinical trials to evaluate its safety and effectiveness in treating several diseases.

What Conditions Does Etrasimod Treat?

Etrasimod is being studied for the treatment of several autoimmune conditions, including:

  • Ulcerative Colitis: A chronic inflammatory bowel disease that affects the lining of the large intestine (colon) and rectum.
  • Crohn's Disease: Another type of inflammatory bowel disease that can affect any part of the digestive tract.
  • Atopic Dermatitis: Also known as eczema, this is a chronic skin condition that causes itchy, inflamed skin.
  • Alopecia Areata: An autoimmune disorder that causes hair loss on the scalp and other parts of the body.
  • Eosinophilic Esophagitis: A chronic immune condition that affects the esophagus (the tube that connects the mouth to the stomach).

How Does Etrasimod Work?

Etrasimod is a type of medication called a sphingosine-1-phosphate (S1P) receptor modulator. It works by targeting specific receptors in the body that are involved in the immune system's response. By modulating these receptors, etrasimod may help reduce inflammation and control the overactive immune response seen in autoimmune conditions.

How is Etrasimod Administered?

Etrasimod is taken orally as a tablet, typically once daily. In clinical trials, it is being tested in various doses, including 2 mg and 3 mg tablets. Some studies are also exploring the use of mini tablets that can be mixed with food or water to make it easier for some patients to take.

Ongoing Clinical Trials

Etrasimod is currently being studied in several clinical trials for different conditions:

  • Phase 2/3 trials for moderate to severe atopic dermatitis.
  • Phase 2/3 trials for moderately to severely active Crohn's disease.
  • Phase 2 and 3 trials for moderately to severely active ulcerative colitis in adults and adolescents,.
  • Phase 2 trial for moderate to severe alopecia areata.
  • Phase 2 trial for active eosinophilic esophagitis.

These trials are designed to evaluate the safety and effectiveness of etrasimod compared to placebo (a dummy pill with no active ingredient) or other treatments.

Potential Side Effects

As with all medications, etrasimod may cause side effects. The full range of potential side effects is still being studied in clinical trials. Some of the aspects being monitored include:

  • Changes in heart rate
  • Changes in blood test results
  • Effects on vital signs (such as blood pressure)
  • Any unexpected adverse events

It's important to note that the safety profile of etrasimod is still being established through ongoing clinical trials.

Future Research and Potential

Etrasimod is showing promise in the treatment of various autoimmune conditions. Ongoing research is focused on:

  • Determining the most effective doses for different conditions
  • Evaluating long-term safety and efficacy
  • Exploring its use in different patient populations, including adolescents with ulcerative colitis
  • Assessing its effectiveness in real-world settings

As research continues, more information will become available about the potential benefits and risks of etrasimod. Patients interested in this medication should discuss it with their healthcare provider to determine if it might be an appropriate treatment option for their condition.

Questions people often ask

Conditions where Etrasimod is being studied

Each condition opens its own overview and trial list

Trials with Etrasimod

Recruiting trials first

See all 1 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.